210 related articles for article (PubMed ID: 33050864)
1. Multi-Target Directed Compounds with Antioxidant and/or Anti- Inflammatory Properties as Potent Agents for Alzheimer's Disease.
Papagiouvannis G; Theodosis-Nobelos P; Kourounakis PN; Rekka EA
Med Chem; 2021; 17(10):1086-1103. PubMed ID: 33050864
[TBL] [Abstract][Full Text] [Related]
2. Activity of Selected Group of Monoterpenes in Alzheimer's Disease Symptoms in Experimental Model Studies-A Non-Systematic Review.
Wojtunik-Kulesza K; Rudkowska M; Kasprzak-Drozd K; Oniszczuk A; Borowicz-Reutt K
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298986
[TBL] [Abstract][Full Text] [Related]
3. Management of oxidative stress and other pathologies in Alzheimer's disease.
Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
[TBL] [Abstract][Full Text] [Related]
4. Nipecotic Acid Derivatives as Potent Agents against Neurodegeneration: A Preliminary Study.
Papagiouvannis G; Theodosis-Nobelos P; Rekka EA
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296574
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation and molecular docking study of novel piperidine and piperazine derivatives as multi-targeted agents to treat Alzheimer's disease.
Meena P; Nemaysh V; Khatri M; Manral A; Luthra PM; Tiwari M
Bioorg Med Chem; 2015 Mar; 23(5):1135-48. PubMed ID: 25624107
[TBL] [Abstract][Full Text] [Related]
6. A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease.
Singh YP; Rai H; Singh G; Singh GK; Mishra S; Kumar S; Srikrishna S; Modi G
Eur J Med Chem; 2021 Apr; 215():113278. PubMed ID: 33662757
[TBL] [Abstract][Full Text] [Related]
7. Multi-target-directed ligands in Alzheimer's disease treatment.
Bajda M; Guzior N; Ignasik M; Malawska B
Curr Med Chem; 2011; 18(32):4949-75. PubMed ID: 22050745
[TBL] [Abstract][Full Text] [Related]
8. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N
Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578
[TBL] [Abstract][Full Text] [Related]
9. Computational approach to suggest a new multi-target-directed ligand as a potential medication for Alzheimer's disease.
Eslami M; Nezafat N; Negahdaripour M; Ghasemi Y
J Biomol Struct Dyn; 2019 Nov; 37(18):4825-4839. PubMed ID: 30689517
[TBL] [Abstract][Full Text] [Related]
10. Molecular docking, synthesis and biological evaluation of phenacyl derivatives of 9-aminoacridine as anti-Alzheimer's agent.
Munawar R; Mushtaq N; Ahmad A; Saeed SMG; Usmani S; Akhtar S; Saify ZS; Arif M; Akram A
Pak J Pharm Sci; 2020 Mar; 33(2):659-668. PubMed ID: 32276912
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease.
Han J; Du Z; Lim MH
Acc Chem Res; 2021 Oct; 54(20):3930-3940. PubMed ID: 34606227
[TBL] [Abstract][Full Text] [Related]
12. Comparative Kinetics of Acetyl- and Butyryl-Cholinesterase Inhibition by Green Tea Catechins|Relevance to the Symptomatic Treatment of Alzheimer's Disease.
Okello EJ; Mather J
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32326457
[TBL] [Abstract][Full Text] [Related]
13. Cognitive enhancement therapy for Alzheimer's disease. The way forward.
Parnetti L; Senin U; Mecocci P
Drugs; 1997 May; 53(5):752-68. PubMed ID: 9129864
[TBL] [Abstract][Full Text] [Related]
14. Natural product for the treatment of Alzheimer's disease.
Bui TT; Nguyen TH
J Basic Clin Physiol Pharmacol; 2017 Sep; 28(5):413-423. PubMed ID: 28708573
[TBL] [Abstract][Full Text] [Related]
15. Association between chronic stress and Alzheimer's disease: Therapeutic effects of Saffron.
Saeedi M; Rashidy-Pour A
Biomed Pharmacother; 2021 Jan; 133():110995. PubMed ID: 33232931
[TBL] [Abstract][Full Text] [Related]
16. Small Molecule Natural Products and Alzheimer's Disease.
Wu X; Cai H; Pan L; Cui G; Qin F; Li Y; Cai Z
Curr Top Med Chem; 2019; 19(3):187-204. PubMed ID: 30714527
[TBL] [Abstract][Full Text] [Related]
17. A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease.
Korabecny J; Spilovska K; Mezeiova E; Benek O; Juza R; Kaping D; Soukup O
Curr Med Chem; 2019; 26(30):5625-5648. PubMed ID: 29768996
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer's disease based on the fusion of donepezil and melatonin.
Wang J; Wang ZM; Li XM; Li F; Wu JJ; Kong LY; Wang XB
Bioorg Med Chem; 2016 Sep; 24(18):4324-4338. PubMed ID: 27460699
[TBL] [Abstract][Full Text] [Related]
19. Recent Multi-target Approaches on the Development of Anti- Alzheimer's Agents Integrating Metal Chelation Activity.
Chaves S; Várnagy K; Santos MA
Curr Med Chem; 2021; 28(35):7247-7277. PubMed ID: 33602068
[TBL] [Abstract][Full Text] [Related]
20. Ferulic acid and Alzheimer's disease: promises and pitfalls.
Nabavi SF; Devi KP; Malar DS; Sureda A; Daglia M; Nabavi SM
Mini Rev Med Chem; 2015; 15(9):776-88. PubMed ID: 26002710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
